<DOC>
	<DOC>NCT02560272</DOC>
	<brief_summary>The study will evaluate the safety and immunogenicity of a haemophilus influenzae type b conjugate vaccine (Hib) in Healthy Children 2 Months to 5 Years of Age who have not been previously immunized with a Hib vaccine. Children 2 to 5 months of age will receive 3 doses of Hib vaccine, Children 6 to 11 months of age will receive 2 doses of Hib vaccine, Children 1 to 5 years of age will receive 1 dose of Hib vaccine, with each dose given approximately 1 month apart.</brief_summary>
	<brief_title>Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Haemophilus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy permanent residence 2 months to 5 years old. Subjects who the investigator believes will comply with the requirements of the protocol should be enrolled in the study. Subjects and parent/guardian able to attend all scheduled visits and comply with all study procedures. Axillary temperature ≤37.0 ℃. History of Haemophilus influenzae type b infection or vaccination of Haemophilus influenzae type b conjugate vaccine. Allergic history or any SAE after vaccination, such as allergy, urticaria, dyspnea, angioedema, celialgia. Receipt of blood or bloodderived products in the 3 months preceding vaccination Participation in another clinical study investigating a vaccine, drug in the 30 days preceding vaccination. Receipt of any live virus vaccine in the 15 days preceding vaccination. Receipt of any subunit vaccine and inactivated vaccine in the 7 days before vaccination. Febrile illness (temperature ≥ 38°C) in the 3 days or any acute illness/infection in the 7 days preceding vaccination. Thrombocytopenia. History of treatment for thyroid gland disease. Functional or anatomic asplenia. History of eclampsia, epilepsy, encephalopathy and mental disease or family disease. Any condition that, in the judgment of investigator, may affect trial assessment.</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>vaccine</keyword>
	<keyword>haemophilus influenzae type b</keyword>
</DOC>